ArcDia International Oy Ltd is a company for R&D, production and marketing of innovative products for point-of-care testing of infectious diseases, with special emphasis on respiratory tract infections. ArcDia has recently launched a product line for rapid testing of respiratory infections under the mariPOC® trademark. The mariPOC® platform is based on the company proprietary ArcDia™ TPX detection technology (Nature Biotech 2000:18). The TPX technology allows multianalyte rapid testing with fully automated and random-access test system. ArcDia is responsible for manufacturing, marketing and sales of the mariPOC® test system. ArcDia offers automated random-access immunoanalysers and test kits for in vitro diagnostic use. The analysers are designed for multianalyte near-patient testing. They are bench-top in size, highly sensitive, and easy-to-use. The platform is also available for R&D collaboration, licensing, and distribution. ArcDia International Oy is part of the ArcDia Group, founded in 1993.
What is the mariPOC® point-of-care diagnostics system? A new point-of-care test system for respiratory tract infections First test system in the market for multianalyte POC testing Automated random-access antigen detection test For nasopharyngeal swab samples and aspirates, and for throat swabs IVD-CE marked Why to choose mariPOC® for respiratory tract infection diagnostics? Accuracy similar to central labora…
